Skip to main content
. 2016 Aug 27;7(46):74931–74946. doi: 10.18632/oncotarget.11647

Figure 2. Measurement of the tumor burden during treatment of xenografted 2102EP(-R) and NCCIT(-R) cells with 2.5 mg/kg romidepsin or the solvent for 10 days.

Figure 2

Inlay: photos of tumors of solvent (left) and romidepsin (right) treated mice after 10 days. n. s. = not significant, p-value > 0.05; asterisk = significant, p-value < 0.05.